← Back to Search

WiseApp for HIV

N/A

Recruiting

Led By Rebecca Schnall, PhD, MPH

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Having been diagnosed with HIV ≥6 months ago

Aged ≥18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 month follow up, 6 month follow up, and 12 month follow up

Awards & highlights

Study Summary

This trial will adapt a mobile app and a smart pill dispenser for Spanish-speaking people living with HIV in NYC and the Dominican Republic. They will assess the efficacy and sustainability of the app, as well as identify barriers to its widespread use among Spanish speakers.

Who is the study for?

This trial is for Spanish-speaking adults living with HIV in NYC or La Romana, DR. Participants must have been diagnosed at least 6 months ago, have an HIV-1 RNA level >50 copies/mL, own a smartphone, and be willing to join any part of the study. It's not for those in long-term care facilities, planning to move soon, from the same household as another participant, terminally ill or with certain cognitive impairments.Check my eligibility

What is being tested?

The WiseApp mobile app and smart pill dispenser are being tested over a year-long randomized controlled trial among Spanish speakers with HIV. The goal is to adapt these technologies for better engagement and clinical outcomes by understanding barriers specific to this group.See study design

What are the potential side effects?

Since WiseApp is a technology-based intervention without direct medical treatments or drugs involved, there may not be traditional side effects; however participants might experience privacy concerns or stress related to using new technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was diagnosed with HIV more than 6 months ago.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 month follow up, 6 month follow up, and 12 month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 month follow up, 6 month follow up, and 12 month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 month follow up, 6 month follow up, and 12 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in self-reported ART adherence

Secondary outcome measures

Change In Participant's Self-reported Health-related Quality of Life Score

Change in Viral Load

Change in cluster of differentiation 4 (CD4) Count

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

WiseApp that delivers medication adherence reminders

Group II: ControlActive Control1 Intervention

The control includes standard health services offered at each site (e.g., mental health services, case-management, referral to clinical care) and a brief adherence educational session.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,433 Previous Clinical Trials

2,447,011 Total Patients Enrolled

Clínica de Familia La Romana, Dominican RepublicUNKNOWN

Rebecca Schnall, PhD, MPHPrincipal InvestigatorColumbia University

2 Previous Clinical Trials

140 Total Patients Enrolled

Media Library

WiseApp Clinical Trial Eligibility Overview. Trial Name: NCT05398185 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Intervention, Control

Human Immunodeficiency Virus Infection Clinical Trial 2023: WiseApp Highlights & Side Effects. Trial Name: NCT05398185 — N/A

WiseApp 2023 Treatment Timeline for Medical Study. Trial Name: NCT05398185 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for participants to join this research experiment?

"Data hosted on clinicaltrials.gov reveals that this medical study is not accepting participants at the present moment. The trial was first posted to their site in January of 2023, and last updated in November 2022. Though recruitment for this particular experiment has ended, there are still 680 other studies actively seeking patients across a variety of conditions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

WiseApp for Spanish Speakers Living With HIV

Rebecca Schnall, RN, MPH, PhD 2023. "WiseApp for Spanish Speakers Living With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05398185.

All > Aids